Hier finden Sie Veranstaltungen der BUKO Pharma-Kampagne sowie Veranstaltungen, bei denen MitarbeiterInnen der Pharma-Kampagne als ReferentInnen auftreten. Darüber hinaus finden Sie hier Hinweise zu anderen Tagungen / Seminaren / Kongressen
6. -7. Juni 2013: Medical Behavior in a Commercial World: Who Is Responsible?"
PharmedOut is a Georgetown University Mecal Center project that advances evidence-based prescribing and educates healthcare professionals about pharmaceutical marketing practices.
The conference will explore the ethical responsibilities of health care providers, medical journals, industry, and payers on therapeutic choices, as well as the effects on public health at large.
Speakers are among others: Carl Elliott, MD, PhD, Author of White Coat, Black Hat, Diana Zuckerman, PhD, President of National Research Center for Women & Families, Joel Lexchin, MD, York University, Marcia Angell, MD, Harvard University, former editor of NEJM, Virginia Barbour, MD, Chief Editor, PLOS Medicine, Charles Ornstein, Senior Editor, ProPublica as well as a ghostwriter who helped sell Low-T syndrome and a former pharmaceutical executive from a top 5 company.
Ort: Washington D.C. / USA
10. - 12. September 2013: Preventing overdiagnosis
The Preventing Overdiagnosis conference is hosted by The Dartmouth Institute for Health Policy and Clinical Practice, in partnership with one of the world’s most respected medical journals, the BMJ, the leading New-York based consumer organisation Consumer Reports, and Bond University.
Leading questions through the whole conference are: What is overdiagnosis? What do we know about overdiagnosis? What can we do about overdiagnosis?
As it moves through these three questions, the conference will have two interrelated themes or tracks. One theme will explore the science and methods used to identify and quantify over-diagnosis, and more than half of the conference will comprise scientific presentations. The other related theme explores the meaning of over-diagnosis, what’s driving it and how best to respond to it, with a focus on communicating information about overdiagnosis to health professionals, policy makers and the public.
Ort: The Darthmore Insitute for Health Policy and Clinical Practice / USA